COVID-19 Testing for the Essential Workforce
Learn about our efforts to test people on the front line and how you can help.
No! Participation in a study is free.
If you'd like to obtain your individual results, you may do so for a discounted fee of $195, which covers the basic costs of processing the test.
Joining a study is not a way to directly order your KRAS-variant results. However, you do have the option to obtain your individual results if you are eligible, through a physician of your choice for a discounted fee of $195, which covers the basic costs of processing the test.
If you're only interested in receiving your KRAS-variant results, you can directly order them here through MiraDx.
After we receive your survey, we will mail you a consent form. Once the consent form is returned to us, you will receive a DNA collection kit in the mail from MiraKind.
After you perform a simple cheek swab, put your sample in the pre-paid envelope and mail it back to us.
MiraKind will analyze study participants’ DNA samples to answer research question(s). Some of you may receive a follow-up study-specific questionnaire to help us gain a more understanding of your health history.
All study participants will have the opportunity to be among the first to learn about the research findings through a MiraKind webinar that will take place at the conclusion of each study.
MiraKind was founded as a nonprofit research organization in 2013 by Joanne Weidhaas, MD, PhD., following her discovery of the KRAS-variant, an inherited genetic mutation associated with an increased risk of cancer. We conduct research on a new class of genetic markers that provides powerful information to help people make personalized health decisions, especially around cancer.